今日VC

Backed by Flagship Ventures and Third Rock Ventures
CAMBRIDGE, Mass., February 17, 2010– Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the [...]

Proceeds Will Further Advance Liprotamase Commercialization Efforts
CAMBRIDGE, Mass., January 28, 2010– Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors [...]

Pappas, Third Rock, Domain and New Leaf Launch New Company Centered on Novel Pain Management Technology; Afferent to Initiate Clinical Trials in First Half of 2010
BASEL, Switzerland & PALO ALTO, Calif., December 16, 2009– Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it has licensed its P2X31 receptor program aimed at developing first-in-class treatments for [...]

New Roles Deepen Expertise in Entrepreneurship, Scientific Evaluation, Clinical Development and Talent Acquisition
BOSTON, July 21, 2009– Third Rock Ventures, L.L.C., a venture capital firm focused on launching leading life sciences companies, today announced the appointment of Philip R. Reilly, M.D., as Venture Partner, Gregory L. Verdine, Ph.D., as Venture Partner, and Craig M. Greaves as [...]